SCHEMBL17034868

SCHEMBL17034868

Cc1ccc(-c2nc3ccccc3c3c2ccc2ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
KDM4E B2RXH2 3/20 0.56
ALDH1A1 P00352 2/20 0.56
ADORA2A P29274 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.49
POLB P06746 3/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 4/20 0.46
NPC1 O15118 2/20 0.46
XBP1 P17861 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 1/20 0.45
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP1B1 Q16678 1/20 0.44
HPGD P15428 1/20 0.43
TNKS O95271 1/20 0.43
PARP1 P09874 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200601 0.89 NUDT1 (0.47) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL18200600 0.89 NUDT1 (0.47) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL17034863 0.89 NUDT1 (0.50) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL17034886 0.84 MEN1 (0.56) TDP1KDM4EADORA2AL3MBTL1LMNA
SCHEMBL18200643 0.84 LMNA (0.45) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL17034864 0.84 CYP1B1 (0.44) KDM4EALDH1A1ADORA2ARAB9ANPC1
SCHEMBL18347016 0.84 MAOA (0.48) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL17034867 0.84 LMNA (0.60) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL18200599 0.83 NUDT1 (0.42) TDP1KDM4EALDH1A1ADORA2AL3MBTL1
SCHEMBL18201033 0.83 ESR1 (0.42) KDM4EALDH1A1ADORA2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 TDP1 3046/4885KDM4E 3143/4885ALDH1A1 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.